Early detection of RCC faces unique challenges. As one of the lowest-shedding tumors with few recurrent mutations, genomic approaches remain limited. Novel cfDNA methylation profiling shows promise for non-invasive diagnosis, offering potential breakthroughs in precision medicine. #Oncology
1 / 4
Comments